NASDAQ:MEDS TRxADE HEALTH (MEDS) Stock Price, News & Analysis $6.43 -0.63 (-8.92%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$6.43▼$8.0050-Day Range$6.35▼$22.4252-Week Range$3.69▼$44.56Volume23,914 shsAverage Volume42,653 shsMarket Capitalization$9.39 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get TRxADE HEALTH alerts: Email Address Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade About TRxADE HEALTH Stock (NASDAQ:MEDS)TRxADE HEALTH, Inc. operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace. It also distributes prescription medication, medical devices, and over the counter medication to pharmacies and medical clinics; and offers pricing transparency, purchasing capabilities, and other value-added services, as well as telehealth services. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. was founded in 2010 and is headquartered in Lutz, Florida.Read More MEDS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MEDS Stock News HeadlinesAugust 18, 2024 | msn.comCheaper prescription drugs, an mpox emergency and rising cancer deaths in men: Here's what made headlines in health this week.August 17, 2024 | msn.comCost Cuts Are Coming for 10 Drugs: What People on Medicare Should KnowSeptember 7, 2024 | Porter & Company (Ad)Trump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…August 17, 2024 | usatoday.comWhich 10 prescription drugs will see major price drops in 2026? What to know about Biden Medicare announcement in TennesseeAugust 16, 2024 | msn.com10 popular drugs see price cuts as Medicare negotiates for first timeAugust 16, 2024 | msn.comSome doctors are embracing compounded versions of popular weight loss drugsAugust 15, 2024 | yahoo.comMedicare announces lower prices on 10 common, high-cost drugsAugust 15, 2024 | msn.comAnimal tranquilizer mixed with illicit drugs has Santa Cruz County health officials concernedSeptember 7, 2024 | Porter & Company (Ad)Trump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…August 15, 2024 | msn.comFactbox-Top Medicare drugs headed for price cutsAugust 13, 2024 | msn.comCOVID-19 drugs: Are there any that work?August 6, 2024 | nz.finance.yahoo.com4E40.SG,0P0001JK3J,0 (4E40.SG)August 5, 2024 | finance.yahoo.comTRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC’s Executive Leadership TeamAugust 5, 2024 | globenewswire.comTRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC's Executive Leadership TeamJuly 30, 2024 | msn.comThese Medications Can Make It Harder to Stay Cool When It’s Hot OutJuly 26, 2024 | globenewswire.comTRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 MillionJuly 21, 2024 | msn.comHow to Get These Anxiety Meds From a DoctorJuly 9, 2024 | globenewswire.comTRxADE Health, Inc. Announces Special Cash DividendSee More Headlines Receive MEDS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 7/24 Dividend7/19/2024Dividend Payable7/24/2024Last Earnings8/09/2024Today9/07/2024Fiscal Year End12/31/2024Next Earnings (Estimated)1/21/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Drugs, proprietaries, & sundries Sub-IndustryWholesale Current SymbolNASDAQ:MEDS CUSIPN/A CIK1382574 Webwww.trxade.com Phone(800) 261-0281Fax800-265-6932Employees50Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-17,840,000.00 Net Margins-149.81% Pretax Margin-250.53% Return on Equity-196.79% Return on Assets-112.21% Debt Debt-to-Equity RatioN/A Current Ratio4.18 Quick Ratio4.18 Sales & Book Value Annual Sales$8.27 million Price / Sales1.14 Cash FlowN/A Price / Cash FlowN/A Book Value$8.08 per share Price / Book0.80Miscellaneous Outstanding Shares1,460,000Free Float725,000Market Cap$9.39 million OptionableNot Optionable Beta2.32 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Surendra K. Ajjarapu (Age 53)Founder, Chairman, CEO & Secretary Comp: $354.23kMr. Prashant Patel R.Ph. (Age 50)Founder, President, COO, Interim CFO, Interim Principal Financial & Accounting Officer and Director Comp: $147.04kDr. Ramesh KenchappaChief Scientific OfficerMr. David M. Saslow Esq.Inhouse CounselDr. Shafaat Pirani Pharm.D.Executive Vice President of Alliance Pharma Solutions, LLCKey CompetitorsHydrofarm Holdings GroupNASDAQ:HYFMRave Restaurant GroupNASDAQ:RAVEF45 TrainingNYSE:FXLVGreenlaneNASDAQ:GNLNCBL InternationalNASDAQ:BANLView All CompetitorsInstitutional OwnershipRenaissance Technologies LLCSold 21,682 shares on 8/9/2024Ownership: 0.830%View All Institutional Transactions MEDS Stock Analysis - Frequently Asked Questions How have MEDS shares performed this year? TRxADE HEALTH's stock was trading at $5.20 at the beginning of 2024. Since then, MEDS stock has increased by 23.7% and is now trading at $6.43. View the best growth stocks for 2024 here. How were TRxADE HEALTH's earnings last quarter? TRxADE HEALTH, Inc. (NASDAQ:MEDS) released its earnings results on Friday, August, 9th. The company reported ($1.04) earnings per share for the quarter. The company earned $0.02 million during the quarter. TRxADE HEALTH had a negative trailing twelve-month return on equity of 196.79% and a negative net margin of 149.81%. When did TRxADE HEALTH's stock split? TRxADE HEALTH shares reverse split before market open on Thursday, June 22nd 2023. The 1-15 reverse split was announced on Thursday, June 22nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. Who are TRxADE HEALTH's major shareholders? TRxADE HEALTH's top institutional shareholders include Renaissance Technologies LLC (0.83%). Insiders that own company stock include Surendra K Ajjarapu and Donald G Fell. View institutional ownership trends. How do I buy shares of TRxADE HEALTH? Shares of MEDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of TRxADE HEALTH own? Based on aggregate information from My MarketBeat watchlists, some other companies that TRxADE HEALTH investors own include Advanced Micro Devices (AMD), Biocept (BIOC), iBio (IBIO), Ollie's Bargain Outlet (OLLI), OPKO Health (OPK) and Alto Ingredients (PEIX). This page (NASDAQ:MEDS) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRxADE HEALTH, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TRxADE HEALTH With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
